Skip to main content
HR 4906 116th Congress House

Insulin Price Reduction Act

Official title: To provide patient protections with respect to the cost of insulin.

Introduced: February 14, 2020 Introduced by: DeGette, Diana Democratic · Colorado See on congress.gov
Health Accounting and auditingBusiness recordsDigestive and metabolic diseasesDrug safety, medical device, and laboratory regulation
More subjectsShow fewer subjects
Fraud offenses and financial crimesHealth care costs and insuranceHealth programs administration and fundingInflation and pricesMedicarePrescription drugs
Sign in to write a letter Sign in to watch
This bill died when the 116th Congress ended
It never became law before the 116th Congress (2019–2020) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Oct 30, 2019
Referred to the Subcommittee on Health.
Oct 29, 2019
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Oct 29, 2019
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Latest action October 30, 2019

Referred to the Subcommittee on Health.

 Plain-English summary Congressional Research Service

Insulin Price Reduction Act

This bill prohibits health insurance plan issuers and pharmacy benefits managers (PBMs) from receiving rebates or discounts for insulin from manufacturers who certify that its current insulin list price has been reduced to an amount no greater than what the list price was for the same insulin on July 1, 2006. This restriction does not apply to discounts provided to insurance plan holders at retail sale or to flat-rate fees for service paid to PBMs. Further, insurance plans are prohibited from applying a deductible to insulin that has received such price certification.

A manufacturer may certify insulin prices by submitting to the Department of Health and Human Services data about the list price of any insulin the manufacturer has produced since January 1, 2000, and by setting the current list price for an insulin product at the 2006 rate. To remain certified, a manufacturer may not increase the list price of insulin by more than the annual increase in the medical care consumer price index. A manufacturer may certify the price of an insulin product for which it did not have a list price in 2006 by reducing the list price of such insulin to the weighted average list price in 2006 of specified insulin categories.

This bill also applies to Medicare prescription drug benefits. The bill sets the rebate for insulin under Medicaid based on the average manufacturer price of insulin during the last fiscal quarter of 2019, increasing by the medical care consumer price index thereafter.

 Related & companion bills 1
  • S 2199 Related bill Insulin Price Reduction Act
 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 3
 Cosponsors 53
All 53 Democratic 28 Republican 2
D
Gonzalez, Vicente
Texas · Sep 11, 2020
 D
Velázquez, Nydia M.
New York · Sep 11, 2020
SERRANO, JOSE
· Jul 31, 2020
Blumenauer, Earl
· Jul 9, 2020
 D
Cohen, Steve
Tennessee · Jul 9, 2020
 D
García, Jesús G. "Chuy"
Illinois · Jul 9, 2020
Luria, Elaine
· Jul 9, 2020
 D
Thompson, Bennie G.
Mississippi · Jul 9, 2020
 D
Castro, Joaquin
Texas · Jun 22, 2020
 D
Craig, Angie
Minnesota · Jun 22, 2020
 D
Hayes, Jahana
Connecticut · Jun 22, 2020
Jackson Lee, Sheila
· Jun 22, 2020
 R
Kelly, Mike
Pennsylvania · Jun 22, 2020
 D
Larson, John B.
Connecticut · Jun 22, 2020
Payne, Donald
· Jun 22, 2020
 D
Aguilar, Pete
California · May 27, 2020
Ruppersberger, C.
· May 27, 2020
Axne, Cynthia
· Mar 5, 2020
 D
Boyle, Brendan F.
Pennsylvania · Mar 5, 2020
Cicilline, David
· Mar 5, 2020
CLAY, WM.
· Mar 5, 2020
 D
Connolly, Gerald E.
Virginia · Mar 5, 2020
 D
Davis, Danny K.
Illinois · Mar 5, 2020
Deutch, Theodore
· Mar 5, 2020
Higgins, Brian
· Mar 5, 2020
 D
Kaptur, Marcy
Ohio · Mar 5, 2020
 D
Lee, Susie
Nevada · Mar 5, 2020
LOWEY, NITA
· Mar 5, 2020
 D
McCollum, Betty
Minnesota · Mar 5, 2020
Perlmutter, Ed
· Mar 5, 2020
 D
Pingree, Chellie
Maine · Mar 5, 2020
 D
Schrier, Kim
Washington · Mar 5, 2020
 D
Soto, Darren
Florida · Mar 5, 2020
 D
Bishop, Sanford D.
Georgia · Feb 28, 2020
 D
Dingell, Debbie
Michigan · Feb 28, 2020
Kuster, Ann
· Feb 28, 2020
Maloney, Sean
· Feb 28, 2020
PRICE, DAVID
· Feb 28, 2020
Rose, Max
· Feb 28, 2020
 D
Wasserman Schultz, Debbie
Florida · Feb 28, 2020
 D
Waters, Maxine
California · Feb 28, 2020
 D
Harder, Josh
California · Feb 14, 2020
McAdams, Ben
· Feb 14, 2020
 D
Norton, Eleanor Holmes
District of Columbia · Feb 14, 2020
 D
Stevens, Haley M.
Michigan · Feb 14, 2020
Wild, Susan
· Feb 14, 2020
 D
Davids, Sharice
Kansas · Dec 19, 2019
HASTINGS, ALCEE
· Nov 22, 2019
 R
Fitzpatrick, Brian K.
Pennsylvania · Nov 12, 2019
 D
Garcia, Sylvia R.
Texas · Nov 12, 2019
Page 1 of 2 Next
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 4906: Insulin Price Reduction Act. 116th Congress. Open America. https://openamerica.io/bill/116-HR-4906/
MLA
"H.R. 4906: Insulin Price Reduction Act." 116th Congress, 2026, Open America, https://openamerica.io/bill/116-HR-4906/.
Bluebook (legal)
H.R. 4906, 116th Cong. (2026), https://openamerica.io/bill/116-HR-4906/.
Markdown link
[H.R. 4906: Insulin Price Reduction Act](https://openamerica.io/bill/116-HR-4906/)
Report a problem